EUVIMEDEUVIMED entdecken
MetaanalyseSystematische Übersicht

Impact of pharmacist intervention in reducing vancomycin‐associated acute kidney injury: A systematic review and meta‐analysis

Pan Kunming iD, Jiang Xiaotian, Xu Qing, Xu Chenqi iD, Ding Xiaoqiang, Lv Qian Zhou

British Journal of Clinical Pharmacology · 2023-02 · 89 (2) · 526-535

DOI: 10.1111/bcp.15301 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift British Journal of Clinical Pharmacology, online erschienen am 02.04.2022. Verfasst von Pan Kunming und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, ZhongShan Hospital FuDan University, ShangHai, China. Hauptthemen laut MEDLINE: Vancomycin, Acute Kidney Injury. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Chinese Pharmaceutical Association Hospital Pharmacy Specialized Committee Hospital Pharmacy Research Special Funded Project Youth Project., Chinese Pharmaceutical Association Hospital Pharmacy Specialized Committee Hospital Pharmacy Research Special Funded Project Youth Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

The aim was to quantify the relationship between pharmacist intervention and vancomycin‐associated acute kidney injury (AKI).

Methods

Electronic databases were searched up to August 2020 for meta‐analyses of cohort studies and/or randomized controlled trials. Studies that compared the incidence of AKI in patients between post‐ and prepharmacist intervention were investigated. The primary outcome was incidence of AKI. We also evaluated the influence of pharmacist intervention in risk factors of vancomycin‐associated AKI.

Results

The search strategy retrieved 1744 studies and 34 studies with 19 298 participants were included (22 published articles and 12 abstracts from conference proceedings). Compared with the preintervention group, the postintervention group patients had a significantly lower incidence of vancomycin‐associated AKI: 7.3% for post‐ and 9.6% for preintervention (odds ratio [OR] 0.52, 95% confidence interval [CI]; 0.41, 0.67], P < .00001). The rate of attaining target concentration was significantly higher in the post‐ than preintervention group (OR 2.86, 95% CI [2.23, 3.67], P < .00001). The postintervention group significantly improved the percentage of serum creatinine laboratory tests than preintervention group (OR = 3.24, 95% CI 2.02, 5.19], P < .00001). Patients postintervention had markedly lower risk of mortality than preintervention patients (OR 0.47, 95% CI [0.31, 0.72], P = .0004).

Conclusion

Pharmacist intervention in vancomycin treatment significantly decreased the rate of vancomycin‐associated AKI, while improving efficacy and reducing mortality. We speculate that this is because the pharmacist interventions optimized the rationality of vancomycin therapy, monitoring of vancomycin trough concentration and the monitoring of patients' renal function.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VancomycinAcute Kidney InjuryHumansAnti-Bacterial AgentsPharmacistsRetrospective StudiesCreatinine

Stichwörter der Autor:innen

acute kidney injurymeta-analysispharmacist interventiontherapeutic drug monitoringvancomycin

Substanzen

VancomycinAnti-Bacterial AgentsCreatinine

Autor:innen und Institutionen

  • Department of Pharmacy, ZhongShan Hospital FuDan University, ShangHai, China.
  • Department of Nephrology, ZhongShan Hospital FuDan University, ShangHai, China.

ORCID-Profile: Pan Kunming, Xu Chenqi

Förderung

  • Chinese Pharmaceutical Association Hospital Pharmacy Specialized Committee Hospital Pharmacy Research Special Funded Project Youth Project.
  • Chinese Pharmaceutical Association Hospital Pharmacy Specialized Committee Hospital Pharmacy Research Special Funded Project Youth Project

Zitieren

APA

Kunming, P., Xiaotian, J., Qing, X., Chenqi, X., Xiaoqiang, D., & Qian Zhou, L. (2023). Impact of pharmacist intervention in reducing vancomycin‐associated acute kidney injury: A systematic review and meta‐analysis. British Journal of Clinical Pharmacology, 89(2), 526-535. https://doi.org/10.1111/bcp.15301

Vancouver

Kunming P, Xiaotian J, Qing X, Chenqi X, Xiaoqiang D, Qian Zhou L. Impact of pharmacist intervention in reducing vancomycin‐associated acute kidney injury: A systematic review and meta‐analysis. British Journal of Clinical Pharmacology. 2023;89(2):526-535. doi:10.1111/bcp.15301

BibTeX
@article{Kunming2023,
  author = {Kunming, Pan and Xiaotian, Jiang and Qing, Xu and Chenqi, Xu and Xiaoqiang, Ding and Qian Zhou, Lv},
  title = {Impact of pharmacist intervention in reducing vancomycin‐associated acute kidney injury: A systematic review and meta‐analysis},
  journal = {British Journal of Clinical Pharmacology},
  year = {2023},
  volume = {89},
  number = {2},
  pages = {526--535},
  doi = {10.1111/bcp.15301}
}
Kostenlos starten →